CHAMPIONS ONCOLOGY, INC. (CSBR) Operating margin 2018–2026
CHAMPIONS ONCOLOGY, INC. (CSBR) operating margin by fiscal year — reported operating income divided by reported revenue.
-1.9%FY2026 · since FY2018: -6.7% → -1.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -1.9% | -9.9 pp |
| FY2025 | 8.0% | +22.7 pp |
| FY2024 | -14.7% | -4.9 pp |
| FY2023 | -9.8% | -11.0 pp |
| FY2022 | 1.2% | +0.3 pp |
| FY2021 | 0.9% | +6.9 pp |
| FY2020 | -6.0% | -7.0 pp |
| FY2019 | 1.0% | +7.7 pp |
| FY2018 | -6.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice